30
Participants
Start Date
March 31, 2007
Primary Completion Date
September 30, 2012
Study Completion Date
September 30, 2012
Daptomycin
6 mg/kg IV every 24 hours for at least 7-14 days, depending on the type of bacteria. Treatment expected to be at least 14 days for SA and at least 7 days for enterococci and CNS, Corynebacterium, and Propionibacterium.
UT MD Anderson Cancer Center, Houston
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
INDUSTRY
M.D. Anderson Cancer Center
OTHER